Phase II study of induction chemotherapy with gemcitabine and S-1 followed by chemoradiotherapy with S-1 in patients with locally advanced pancreatic cancer
Not Applicable
- Conditions
- locally advanced pancreatic cancer
- Registration Number
- JPRN-UMIN000006332
- Lead Sponsor
- Chiba Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
(1)severe concurrent disease (2)interstitial pneumonia, severe pulmonary emphysema or active pnemonia (3)mental disorder (4)active concomitant malignancy (5)moderate or severe diarrhea, hemorrhagic colitis or peptic ulcer (6)severe drug hypersensitibity (7)pregnant or lactating females (8)regular use of phenytoin, warfarin or frucitocin (9)Under treatment with systemic steroid (10)fever of 38 degrees centigrade or higher, or infection requiring systemic treatment (11)inappropriate for entry onto the study, as diagnosed by primary physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1-year survival rate
- Secondary Outcome Measures
Name Time Method